Open an account

Conexeu Sciences

CNXU · NASDAQ

$2.99+$0.00 (+0.00%)TodayMarket closed ·
Prev close $2.99

About CNXU

Conexeu Sciences, Inc. engages in the development of regenerative biomaterials needed in wound care, dentistry, and aesthetics. The company is headquartered in Reno, Nevada. The company went IPO on 2026-05-21. The firm is focused on developing regenerative biomaterials that address significant needs in wound care, dentistry, and aesthetics. The firm is focused on providing physicians with device-based solutions for healing, restoring soft tissue, and improving patient outcomes across multiple clinical settings. Its core device candidate, CXU, is a temperature-responsive ECM scaffold formulation intended to transition in-situ to a gel-like extra cellular matrix (ECM) within approximately minutes (Ten-Minute Tissue). The firm operates and manages its business in one operating segment, which is developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics.

Employees
0
Headquarters
Reno, Nevada
Listed
May 21, 2026
Sector
Health Care
Industry
Biotechnology
Website
conexeu.com

CNXU key statistics

Market cap
84.34M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
315.94K
Volume
254
Open price
$3.33
High today
$3.60
Low today
$2.95
52 Week high
$18.79
52 Week low
$3.05

Conexeu Sciences (CNXU) at a glance

As of Oct 21, 2026, Conexeu Sciences (CNXU) shares are priced at $2.99, giving the company a market cap of 84.34M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.95 and $3.60. The current price is 1.4% above the day's low and 16.9% below its high.

Volume so far is 254 shares, below the average of 315.94K shares a day.

Over the past year Conexeu Sciences has ranged from $3.05 to $18.79, and now sits 0% of the way up that range.

The average analyst price target is $20.40, 582.3% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 3 analystsAvg $20.40
Low
$20.20
Now
$2.99
High
$21.00

CNXU news

  • Press releaseGlobe Newswire

    Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors

  • Press releaseGlobe Newswire

    Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

  • Press releaseGlobe Newswire

    Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission

  • Press releasePRNewswire

    A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

  • Press releaseGlobe Newswire

    Conexeu Sciences Sets September and October 2026 Conference Schedule

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.

  • Press releaseGlobe Newswire

    The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too.

Similar companies

Companies in the same industry as Conexeu Sciences

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.